Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pergolide mesylate salt(LY127809) is a long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 67.00 | |
25 mg | In stock | $ 117.00 | |
50 mg | In stock | $ 187.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 52.00 |
Description | Pergolide mesylate salt(LY127809) is a long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES. |
Synonyms | Pergolide mesylate salt, LY127809, Pergolide methanesulfonate |
Molecular Weight | 410.59 |
Formula | C20H30N2O3S2 |
CAS No. | 66104-23-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL
H2O: 40 mg/mL (97.4 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pergolide mesylate 66104-23-2 GPCR/G Protein Neuroscience 5-HT Receptor Dopamine Receptor Adrenergic Receptor disease D2-receptor Parkinson's inhibit Inhibitor MDA LY-127809 Pergolide hyperprolactinaemia Pergolide mesylate salt neuroprotection LY127809 D1-receptors Pergolide methanesulfonate LY 127809 Pergolide Mesylate ergoline inhibitor